Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUCMSC-Exos for Androgenic Alopecia
NCT07373054Completed
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Nov 2025
- Primary completion
- Jul 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Randomised trial of human umbilical cord mesenchymal stem cell-derived exosomes in androgenetic alopecia (AGA) (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Hair Density in the Alopecia Area at 24 weeks, Mean Change in Hair Shaft Diameter at 24 weeks and 2 more. Started Nov 2025; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cell-derived exosomes
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07373054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07373054.